Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MARRONE BIO INNOVATIONS, INC.

(MBII)
  Report
Delayed Quote. Delayed Nasdaq - 09/24 04:00:00 pm
0.989 USD   -3.04%
09/24NOV 18 : Biologicals & Best Practices for Stone Fruit
PU
09/24OCT 7 : Fogging for Indoor Growing
PU
09/24SEPT 30 : Biologicals & Best Practices for Strawberries
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Marrone Bio Innovations : Rizobacter, Marrone Bio Innovations to Supply Novel Seed Treatment Rizonema in Brazil

07/12/2021 | 10:23am EDT


ę MT Newswires 2021
All news about MARRONE BIO INNOVATIONS, INC.
09/24NOV 18 : Biologicals & Best Practices for Stone Fruit
PU
09/24OCT 7 : Fogging for Indoor Growing
PU
09/24SEPT 30 : Biologicals & Best Practices for Strawberries
PU
09/22MARRONE BIO INNOVATIONS : Roth Capital Reinstates Coverage on Marrone Bio Innovations With..
MT
09/20MARRONE BIO INNOVATIONS, INC.(NASDAQ : MBII) added to S&P Global BMI Index
CI
09/09MARRONE BIO INNOVATIONS : Readies Regulatory Submissions for New Pesticides in US, Brazil
MT
09/09MARRONE BIO INNOVATIONS : Prepares to Submit Registration for Next-Generation Crop Protect..
AQ
09/09Marrone Bio Innovations, Inc. Prepares to Submit Registration for Next-Generation Crop ..
CI
08/30MARRONE BIO INNOVATIONS INC : Change in Directors or Principal Officers (form 8-K)
AQ
08/30Marrone Bio Innovations, Inc. Announces Resignation of Kevin Hammill from Chief Manufac..
CI
More news
Analyst Recommendations on MARRONE BIO INNOVATIONS, INC.
More recommendations
Financials (USD)
Sales 2021 44,5 M - -
Net income 2021 -15,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -11,2x
Yield 2021 -
Capitalization 174 M 174 M -
Capi. / Sales 2021 3,92x
Capi. / Sales 2022 2,91x
Nbr of Employees 145
Free-Float 98,3%
Chart MARRONE BIO INNOVATIONS, INC.
Duration : Period :
Marrone Bio Innovations, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MARRONE BIO INNOVATIONS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 0,99 $
Average target price 2,53 $
Spread / Average Target 155%
EPS Revisions
Managers and Directors
Kevin R. Helash Chief Executive Officer & Director
Sue Cheung Chief Financial Officer
Robert A. Woods Chairman
Amit Vasavada Chief Technology Officer, Senior VP-R&D
Linda V. Moore Secretary, Chief Compliance Officer & EVP